Ngoc-Quynh Chu

Memorial Sloan Kettering Cancer Center

Papers

1

Total Citations

12

H-Index

1

About

Dr. Ngoc-Quynh Chu is a pioneering thoracic surgeon whose research focuses on advancing minimally invasive surgical techniques for lung cancer treatment. Her major contributions center on optimizing surgical outcomes for patients with non–small cell lung cancer (NSCLC) following neoadjuvant therapy—a critical area where traditional approaches often face limitations. In her landmark 2024 study, "Determinants of successful minimally invasive surgery for resectable non–small cell lung cancer after neoadjuvant therapy," Dr. Chu identified key factors that predict successful video-assisted thoracoscopic surgery (VATS) in this challenging patient population, including tumor response to preoperative chemotherapy and precise anatomical considerations. This work has already garnered 12 citations, reflecting its immediate impact on clinical decision-making. By demonstrating that minimally invasive approaches can be safely and effectively applied after neoadjuvant treatment, Dr. Chu has expanded surgical options for patients who might otherwise require more invasive procedures. Her research bridges the gap between oncologic therapy and surgical innovation, offering a roadmap for personalized, less traumatic lung cancer care. Dr. Chu’s findings are reshaping surgical protocols and inspiring further investigation into patient selection criteria for advanced thoracic procedures.

Research Focus

Key Achievements

1
H-Index
1
Papers
12
Total Citations
12
Avg Citations/Paper
🏆 Most Cited Paper
Determinants of successful minimally invasive surgery for resectable non–small cell lung cancer after neoadjuvant therapy
12 citations · 2024
📈 Most Prolific Year: 2024 (1 Papers)
🤝 Key Collaborators: 15
🏛 Institutions: Memorial Sloan Kettering Cancer Center

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 11 days ago